Considering innate immune responses in SARS-CoV-2 infection and COVID-19

During the COVID-19 pandemic, much of the media focus has been on adaptive immunity, particularly antibody levels and memory T cells. However, immunologists have been striving to decipher how SARS-CoV-2 infection impacts our first line of defence, namely the innate immune system. In early 2022, Prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamond, Michael S., Lambris, John D., Ting, Jenny P., Tsang, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252555/
https://www.ncbi.nlm.nih.gov/pubmed/35788185
http://dx.doi.org/10.1038/s41577-022-00744-x
_version_ 1784740289668186112
author Diamond, Michael S.
Lambris, John D.
Ting, Jenny P.
Tsang, John S.
author_facet Diamond, Michael S.
Lambris, John D.
Ting, Jenny P.
Tsang, John S.
author_sort Diamond, Michael S.
collection PubMed
description During the COVID-19 pandemic, much of the media focus has been on adaptive immunity, particularly antibody levels and memory T cells. However, immunologists have been striving to decipher how SARS-CoV-2 infection impacts our first line of defence, namely the innate immune system. In early 2022, Program staff from the NIAID at the NIH organized a workshop focusing on the innate immune response to SARS-CoV-2 infection and during COVID-19, which was chaired by Ralph Baric, Jenny Ting and John Lambris. Following the meeting, Nature Reviews Immunology invited some of the organizers and speakers to share their thoughts on the key discussion points.
format Online
Article
Text
id pubmed-9252555
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92525552022-07-05 Considering innate immune responses in SARS-CoV-2 infection and COVID-19 Diamond, Michael S. Lambris, John D. Ting, Jenny P. Tsang, John S. Nat Rev Immunol Viewpoint During the COVID-19 pandemic, much of the media focus has been on adaptive immunity, particularly antibody levels and memory T cells. However, immunologists have been striving to decipher how SARS-CoV-2 infection impacts our first line of defence, namely the innate immune system. In early 2022, Program staff from the NIAID at the NIH organized a workshop focusing on the innate immune response to SARS-CoV-2 infection and during COVID-19, which was chaired by Ralph Baric, Jenny Ting and John Lambris. Following the meeting, Nature Reviews Immunology invited some of the organizers and speakers to share their thoughts on the key discussion points. Nature Publishing Group UK 2022-07-04 2022 /pmc/articles/PMC9252555/ /pubmed/35788185 http://dx.doi.org/10.1038/s41577-022-00744-x Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Viewpoint
Diamond, Michael S.
Lambris, John D.
Ting, Jenny P.
Tsang, John S.
Considering innate immune responses in SARS-CoV-2 infection and COVID-19
title Considering innate immune responses in SARS-CoV-2 infection and COVID-19
title_full Considering innate immune responses in SARS-CoV-2 infection and COVID-19
title_fullStr Considering innate immune responses in SARS-CoV-2 infection and COVID-19
title_full_unstemmed Considering innate immune responses in SARS-CoV-2 infection and COVID-19
title_short Considering innate immune responses in SARS-CoV-2 infection and COVID-19
title_sort considering innate immune responses in sars-cov-2 infection and covid-19
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252555/
https://www.ncbi.nlm.nih.gov/pubmed/35788185
http://dx.doi.org/10.1038/s41577-022-00744-x
work_keys_str_mv AT diamondmichaels consideringinnateimmuneresponsesinsarscov2infectionandcovid19
AT lambrisjohnd consideringinnateimmuneresponsesinsarscov2infectionandcovid19
AT tingjennyp consideringinnateimmuneresponsesinsarscov2infectionandcovid19
AT tsangjohns consideringinnateimmuneresponsesinsarscov2infectionandcovid19

Ejemplares similares